New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 26, 2014
10:00 EDTTDC, MAS, GBCI, UNT, SQI, BIN, ARIA, RL, ARMS, FCH, LNKD, EXLP, KR, BRSOn The Fly: Analyst Upgrade Summary
Bristow Group (BRS) upgraded to Overweight from Equal Weight at Barclays... Exterran Partners (EXLP) upgraded to Outperform from Neutral at Credit Suisse... Felcor Lodging (FCH) upgraded to Outperform from Market Perform at JMP Securities... Kroger (KR) upgraded to Overweight from Neutral at JPMorgan... LinkedIn (LNKD) upgraded to Outperform from Sector Perform at RBC Capital... Masco (MAS) upgraded to Hold from Underweight at KeyBanc... Ralph Lauren (RL) upgraded to Outperform from Market Perform at Wells Fargo... SciQuest (SQI) upgraded to Buy from Hold at Canaccord... Teradata (TDC) upgraded to Buy from Neutral at Longbow... ARIAD (ARIA) upgraded to Buy from Hold at Maxim... Unit Corp. (UNT) upgraded to Outperform from Sector Perform at Howard Weil... Amyris (AMRS) upgraded to Market Perform from Underperform at Cowen... Progressive Waste (BIN) upgraded to Outperform from Neutral at Credit Suisse... Glacier Bancorp (GBCI) upgraded to Buy from Neutral at DA Davidson.
News For BRS;EXLP;FCH;KR;LNKD;MAS;RL;SQI;TDC;ARIA;UNT;ARMS;BIN;GBCI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 >>
February 4, 2016
06:58 EDTTDCTeradata reports Q4 EPS 70c, consensus 70c
Subscribe for More Information
06:08 EDTRLGoldman Sachs reports 5.4% passive stake in Ralph Lauren
Goldman Sachs Asset Management discloses a 5.4% passive stake in Ralph Lauren.
05:49 EDTLNKDLinkedIn volatility elevated into Q4 and outlook
Subscribe for More Information
05:04 EDTLNKDStocks with implied volatility above IV index mean; FEYE LNKD
Subscribe for More Information
February 3, 2016
14:48 EDTRLNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include Philip Morris (PM), consensus 81c... AstraZeneca (AZN), consensus 88c... Occidental Petroleum (OXY), consensus (12c)... ConocoPhillips (COP), consensus (65c)... Cigna (CI), consensus $1.80... Intercontinental Exchange (ICE), consensus $3.01... Boston Scientific (BSX), consensus 25c... Charter Communications (CHTR), consensus (12c)... Ralph Lauren (RL), consensus $2.13... Dunkin' Brands (DNKN), consensus 50c... GrubHub (GRUB), consensus 14c... Level 3 (LVLT), consensus 53c... AmerisourceBergen (ABC), consensus $1.25... Cummins (CMI), consensus $2.11.
11:37 EDTMASOptions with increasing put volume; PSX CDNS DF WDR MELI MAS NOV WSM DB
Subscribe for More Information
08:08 EDTRLRalph Lauren volatility elevated into Q3 and outlook
Ralph Lauren February call option implied volatility is at 51, March is at 40; compared to its 52-week range of 16 to 43, suggesting large near term price movement into the expected release of Q3 results on February 4.
07:07 EDTGBCIFIG Partners to hold a forum
Subscribe for More Information
05:08 EDTLNKDStocks with implied volatility above IV index mean; FEYE TWTR
Subscribe for More Information
February 2, 2016
05:07 EDTLNKDStocks with implied volatility above IV index mean; LNKD TWTR
Subscribe for More Information
February 1, 2016
12:48 EDTKROptions with increasing call volume
Subscribe for More Information
10:00 EDTGBCIOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Air Products (APD) upgraded to Buy from Neutral at UBS... American Airlines (AAL) upgraded to Outperform from Market Perform at Cowen... Axiall (AXLL) upgraded to Overweight from Neutral at JPMorgan... BASF (BASFY) upgraded to Buy from Hold at Societe Generale... CNH Industrial (CNHI) upgraded to Neutral from Underperform at BofA/Merrill... CU Bancorp (CUNB) upgraded to Outperform from Market Perform at Fig Partners... CaixaBank (CAIXY) upgraded to Hold from Sell at Societe Generale... Chipotle (CMG) upgraded to Neutral from Underperform at BofA/Merrill... Concho Resources (CXO) upgraded to Buy from Neutral at SunTrust... Continental Building (CBPX) upgraded to Buy from Hold at BB&T... Eastman Chemical (EMN) upgraded to Buy from Outperform at CLSA... Extreme Networks (EXTR) upgraded to Buy from Hold at Needham... Glacier Bancorp (GBCI) upgraded to Outperform from Market Perform at Fig Partners... IBERIABANK (IBKC) upgraded to Strong Buy from Outperform at Raymond James... Infineon (IFNNY) upgraded to Buy from Neutral at UBS... Jarden (JAH) upgraded to Outperform from Market Perform at Raymond James... Joy Global (JOY) upgraded to Overweight from Equal Weight at Barclays... KT Corporation (KT) upgraded to Overweight from Neutral at JPMorgan... Kennametal (KMT) upgraded to Neutral from Underperform at BofA/Merrill... L-3 Communications (LLL) upgraded to Buy on valuation at BofA/Merrill... Maximus (MMS) upgraded to Outperform from Market Perform at Raymond James... Micron (MU) upgraded to Neutral from Sell at Goldman... Monster Beverage (MNST) upgraded to Outperform from Market Perform at Wells Fargo... Newell Rubbermaid (NWL) upgraded to Outperform from Market Perform at Raymond James... Northrop Grumman (NOC) upgraded to Buy from Neutral at BofA/Merrill... PTC (PTC) upgraded to Buy from Neutral at Sterne Agee CRT... Peoples Bancorp (PEBO) upgraded to Outperform from Neutral at Boenning & Scattergood... Praxair (PX) upgraded to Buy from Neutral at UBS... Proofpoint (PFPT) upgraded to Outperform from In-Line at Imperial Capital... Seagate (STX) upgraded to Hold from Sell at Benchmark... Siemens (SIEGY) upgraded to Buy from Neutral at Nomura... Superior Drilling (SDPI) upgraded to Buy from Hold at Wunderlich... Vertex (VRTX) upgraded to Buy from Hold at Jefferies... Werner (WERN) upgraded to Strong Buy from Outperform at Raymond James... ZAIS Financial (ZFC) upgraded to Overweight from Equal Weight at Barclays.
09:34 EDTGBCIGlacier Bancorp upgraded to Outperform from Market Perform at Fig Partners
Subscribe for More Information
07:37 EDTARIAARIAD announces FDA clearance to begin development of AP32788
Subscribe for More Information
07:35 EDTRLRalph Lauren may be next big turnaround in softlines, says UBS
Subscribe for More Information
05:08 EDTLNKDStocks with implied volatility above IV index mean; LNKD TWTR
Subscribe for More Information
January 29, 2016
08:31 EDTFCHFelCor to sell Morgans, Royalton hotels in New York
FelCor Lodging Trust (FCH) announced that it is in negotiations to sell its Morgans and Royalton hotels in New York. Proceeds from these opportunistic asset sales will be used to fund initiatives intended to create significant stockholder value. FelCor and Morgans Hotel Group (MHGC), which operates the hotels, have agreed that FelCor may sell the hotels unencumbered by management. Morgans will continue to manage the properties for FelCor until they are sold.
January 28, 2016
16:38 EDTGBCIGlacier Bancorp reports Q4 EPS 39c, consensus 40c
Subscribe for More Information
16:20 EDTFCHFelcor Lodging says welcomes 'constructive input' from Land and Buildings
Subscribe for More Information
January 27, 2016
19:30 EDTLNKDOn The Fly: After Hours Movers
UP AFTER EARNINGS: Facebook (FB), up 11.4%... Mellanox (MLNX), up 6.4%... Paypal (PYPL), up 5%... Crown Castle (CCI), up 2.2%... Citrix (CTXS), up 2.4%... Las Vegas Sands (LVS), up 1%... SanDisk (SNDK), up 1%. ALSO HIGHER: Radius Health (RDUS), up 1.2% after announcing a clinical collaboration with Novartis (NVS)... LinkedIn (LNKD) is up 2.4%, Alphabet (GOOG, GOOGL) is up 2.2% and 2.6%, respectively, Netflix (NFLX) is up 1%, Amazon.com (AMZN) is up 2%, and Twitter (TWTR) is up marginally after Facebook reported quarterly results... MGM Resorts (MGM) is up 2.2% and Wynn Resorts (WYNN) is up 2.2%. DOWN AFTER EARNINGS: ServiceNow (NOW), down 16.5%... eBay (EBAY), down 12.8%... United Rentals (URI), down 9.7%... Juniper Networks (JNPR), down 9.6%... Silicon Graphics (SGI), down 9.1%... Discover Financial (DFS), down 7.4%... InvenSense (INVN), down 6.1%... Core Laboratories (CLB), down 4.3%... Vertex Pharmaceuticals (VRTX), down 1.1%. ALSO LOWER: Incyte (INCY), down 12.8% after announcing that it will halt the Phase 2 sub-study of ruxolitinib or placebo in combination with regorafenib after a planned interim analysis of the high CRP subgroup demonstrated that ruxolitinib plus regorafenib did not show a sufficient level of efficacy to warrant continuation.
1 | 2 | 3 | 4 | 5 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use